{"nct_id":"NCT01970475","title":"Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2013-10","start_date_type":null,"primary_completion_date":"2014-11","primary_completion_date_type":"ACTUAL","completion_date":"2014-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}